The Journal of Cardiac Failure (JCF) has released a special Focus Issue on Hemodynamics, highlighting the renewed importance ...

A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and ...

A cholesterol-lowering regimen that combines PCSK9 inhibitor alirocumab with statin therapy safely reduced low-density ...

The cardiac MRI team at Kettering General Hospital have won two national awards for the way they work together to provide ...

Host Tylah Tully looks at EBR Systems (ASX:EBR) latest news, as the company enrols its first patients in a key study to ...

While sudden cardiac arrest in a child or adolescent is rare—about 20,000 cases occur each year in the U.S.—the survival rate when it happens outside of a hospital is estimated to be under 20%.

"These findings suggest that while PCSK9 inhibitors are safe and effective at lowering lipids, their impact on early vascular remodeling in heart transplant recipients may be limited -- at least ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...

Catherine, born with Down syndrome and Tetralogy of Fallot (TOF), a rare congenital heart condition, has regained her quality of life after undergoing a novel Venus P™ valve implantation at the ...

Many young people who suffered sudden cardiac death had recently sought medical care. More frequent use of electrocardiograms (ECG) could help prevent ...